Tribunal Confirms Stock Exchange Fees as Capital Expenditure with Depreciation

The Tribunal upheld the decision of the CIT(A) confirming admission fees paid to Stock Exchange as capital expenditure, allowing depreciation on the same. The Tribunal determined that the payment for membership created an intangible right transferable by nomination, constituting a capital asset under Section 37 of the Income-tax Act. Citing relevant case law, it emphasized the lasting benefit aspect of the membership, distinguishing between capital and revenue expenditure. The appeal was dismissed, affirming that the admission fee was rightly treated as capital expenditure, warranting depreciation.

---

---

Issues:
Whether admission fees paid to Stock Exchange is capital expenditure or revenue expenditure.

Analysis:
The appeal was against the CIT(A) Order confirming the disallowance of admission fees paid to Stock Exchange as capital expenditure, despite allowing depreciation on the same. The assessee argued that the payment was for permission to trade and not for acquiring a capital asset. The CIT(A) held it to be a capital expenditure based on precedence. The Tribunal analyzed the nature of the expenditure under Section 37 of the Income-tax Act, distinguishing between capital and revenue expenditure. It examined the rules of the stock exchange regarding membership acquisition, concluding that membership created an intangible right transferable by nomination, constituting a capital asset.

The Tribunal referred to the definition of 'capital asset' under Section 2(14) of the Act, emphasizing the lasting benefit aspect. It cited case law to support that membership of a stock exchange confers valuable rights, qualifying as a capital asset. The distinction between capital and revenue expenditure was explained, highlighting that capital expenditure leads to lasting value acquisition, while revenue expenditure is operational for immediate returns. The Tribunal relied on the Techno Shares and Stocks case, where the Supreme Court treated stock exchange membership as a business right and a capital asset, allowing depreciation.

Further, the Tribunal referenced the Alembic Chemical case, emphasizing that an enduring benefit signifies capital expenditure. It distinguished the Abhipra Capital case, noting that the membership's enduring benefit was crucial in determining capital expenditure. The Tribunal upheld the CIT(A)'s decision, affirming the admission fee as a capital asset and allowing depreciation. The appeal was dismissed, concluding that the admission fee was rightly treated as capital expenditure, and depreciation was to be granted accordingly.

---